Canada: For Your Phase 3 Global Trial Expansion
Oncology continues to be the largest and fastest growing therapeutic area in the clinical trials market, and a market dominated…
What’s Best for Your Phase III Clinical Study?
It’s worth your time to consider whether or not the commonly held belief that using a larger CRO for your…
Special Report: What’s in Store for Global Clinical Trials in 2022 and Beyond?
The Global Clinical Trials Market was valued at $44.3B USD in 2020, and by 2028 is expected to reach $69.3B…
Prime Location for Global Clinical Studies?
Canada is considered one of the most attractive places to live in the world, with a high quality of life,…
Why Not Canada for Your Phase 3 Global Trial Expansion?
Pre-pandemic oncology was both the largest and fastest growing therapeutic area in the clinical trials market. A key market trend…
Let Canada Contribute to Your Basket Trial Success
With the emergence of basket trials in the early-phase oncology setting, clinical research teams are faced with challenges of enrollment…
2020 a Year Like No Other: What it Takes to Keep Ahead of Rapid Change
This time last year none of us imagined we were about to go through a year like no other, and…
Overcome Oncology Clinical Trial Obstacles – 2020 Real World Evidence for 2021 and Beyond
Study start-up is one the most time-intensive areas within clinical drug development, accounting for two thirds or more of total…
Some Facts About Canada… Mitigate COVID-19 Impact on Your Clinical Trials
People often adhere to a myth and perpetuate it in answer to a difficult question, ending all further inquiry into…
Consider This Region for Your Phase 3 Global Trial
As of May 2020 ClinicalTrials.gov lists 16,150 oncology trials registered as Recruiting, Not yet Recruiting Studies, and the chart below…